We are live on ! Find out more
MD icon

Pediatrix Medical

220 hedge funds and large institutions have $2.66B invested in Pediatrix Medical in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 67 increasing their positions, 80 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 18

15% more capital invested

Capital invested by funds: $2.31B → $2.66B (+$342M)

6% more funds holding

Funds holding: 207220 (+13)

2.89% less ownership

Funds ownership: 105.49%102.6% (-2.9%)

16% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 80

20% less call options, than puts

Call options by funds: $7.89M | Put options by funds: $9.81M

Holders
220
Holders Change
+13
Holders Change %
+6.28%
% of All Funds
3.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
32
Increased
67
Reduced
80
Closed
18
Calls
$7.89M
Puts
$9.81M
Net Calls
-$1.92M
Net Calls Change
+$1.96M

MD Hedge Fund Activity: Q2 2021 in Review

220 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q2 2021, worth a combined $2.66B — up 15% from $2.31B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new MD positions and 18 closed out — a net gain of 14 holders — while 67 added to existing stakes and 80 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $23.9M. The largest seller was LSV Asset Management, exiting entirely with an estimated $24.6M sold.

  • 220 institutional investors held Pediatrix Medical (MD) as of Q2 2021, up from 207 in Q1 2021.
  • Funds reported $2.66B of Pediatrix Medical stock for Q2 2021, up 15% quarter-over-quarter.
  • 32 funds opened new Pediatrix Medical positions in Q2 2021 and 18 closed out, a net change of +14 holders.
  • The largest Pediatrix Medical buyer in Q2 2021 was Arrowstreet Capital, an estimated $23.9M added.
  • The largest Pediatrix Medical seller in Q2 2021 was LSV Asset Management, an estimated $24.6M sold.

Based on aggregated 13F filings for Q2 2021.